CV Sciences’ CBD oil will be sold in 945 Kroger-owned stores across 17 states, it was recently announced.
Investors Said Going Public Would Bring Increase in Investments
For biotechs, what’s the path to an initial public offering like? The CEOs of San Diego companies that took the IPO plunge weighed in on this question and others during a recent Biocom panel.
Joan Herman was recently named to the board of Carlsbad’s Ionis Pharmaceuticals.
Oncternal Retains CEO, Will Remain In San Diego
On the heels of auspicious clinical trial results, San Diego-based Oncternal Therapeutics completed a reverse merger with Tennessee’s GTx, it was announced June 10.
No New Treatments for Targeted Condition in More Than a Decade
La Jolla Pharmaceutical’s stock recently jumped after its drug candidate for regulating iron overload showed promise in preliminary clinical trial results.
HEALTH CARE: Reimbursement Codes Open Door for Revenue
The mental health system is often called broken or fragmented. That’s created an opening for San Diego tech companies.
Co.to Operate as Brickell, Focus on Skin Conditions
After pulling the plug on a herpes vaccine program, San Diego-based Vical is set to merge with Colorado’s Brickell Biotech in an all-stock deal.
Average Wage Is $115,000; Economic Impact Put at $39B
Employment in San Diego’s life sciences industry increased 12.5% from 2013 to 2018, states a new report.
After securing $30 million in a private stock placement in April, Evofem on June 10 closed a second tranche of $50 million.
UC San Diego Health opened an Encinitas facility as part of a bid to expand beyond hospital walls.